Redmile Group, LLC Portfolio Holdings
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
Redmile Group, LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $1.53 Billion distributed in 63 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Krystal Biotech, Inc. with a value of $188M, Amicus Therapeutics, Inc. with a value of $105M, Nurix Therapeutics, Inc. with a value of $92.3M, Stoke Therapeutics, Inc. with a value of $63.8M, and Immunome Inc. with a value of $59.2M.
Examining the 13F form we can see an decrease of $1B in the current position value, from $2.54B to 1.53B.
Redmile Group, LLC is based out at San Francisco, CA
Below you can find more details about Redmile Group, LLC portfolio as well as his latest detailed transactions.